Breaking RM5 is very important. Once break all the way up to RM5.50 then RM6

Genting Singapore result should be out soon. Expect very good.....in Singapore dollars.
Once GenS out, breaking RM5.30 no problem.

This year is WOOD DRAGON.
Genting is on top of the hill with a lot of trees and Wood.
This year is going to be very ONG for Genting Berhad.

Good luck. Just hope for the best and pray that TauRX could bring a fortune this year. So hold tight tight.

Maybe that time he needs money for Genting HK.

If next week GenS or GenP result is very good, Share price sure go up.
Exchange rate convert to Ringgit profit even more for GenB.

According to bursa, if the bosses or any major shareholder is selling, Genting Berhad need to provide detail to bursa and will appear in daily bursa news. So far I didn't see any change of shareholders new in Bursa for a very long times.,

Hold until March 2024.
Genting Bhd’s TauRx Pharmaceuticals’ Alzheimer drugs, which are set to release two years of its Phase Three trial data in March, are also key re-rating catalysts.”
TauRx’s HMTM Phase Three trial may set a milestone towards securing authorities’ approval

More good news and no bad news. Why selling. Should start accumulate. No problem breaking RM5.

https://www.thestar.com.my/business/business-news/2024/02/19/better-gaming-earnings-forecast-for-4q23

Better gaming earnings forecast for 4Q23
“For the casino segment, both Resorts World Genting (RWG) and Resorts World Sentosa (RWS) were packed with visitors queuing to enter the casinos and placing bets during the first week of CNY.

It said the Genting Group is a direct beneficiary of the tourism ramp-up in 2024 with foreign tourist arrivals to Malaysia expected to exceed 2019’s level.

“Positive developments of Genting Malaysia Bhd’s downstate New York’s full-fledged casino licence bid and Genting Bhd’s TauRx Pharmaceuticals’ Alzheimer drugs, which are set to release two years of its Phase Three trial data in March, are also key re-rating catalysts.”

The moratorium for New York’s downstate casino had ended in 2023, and Genting Malaysia’s Resorts World New York City (RWNYC) appeals as one of the frontrunners to secure a full-scale gaming licence.

“We anticipate more newsflow to be released within the first half of 2024 and RWNYC eventually securing a concession which may lift Genting Malaysia’s earnings before interest, taxes, depreciation, and amortisation by US$106mil based on our earlier assumptions,” said UOBKH Research.

On Genting’s 20.33%-owned TauRx, it said positive data from TauRx’s HMTM Phase Three trial may set a milestone towards securing authorities’ approval, which could potentially fetch RM3.45 per share monetisation value for Genting’s stake in TauRx.

The research firm said this was based on assumptions that TauRX was initially eyeing a Nasdaq initial public offering in 2017 with a potential valuation of US$15bil. However, it said it had yet to impute any option value from TauRX.

Aaron Kwok 4 shows in Genting Highland full house.

Slow and steady.
Breaking RM5 soon.

https://theedgemalaysia.com/node/701095

Another notable mention is Genting Bhd. After a flat 2023, analysts have raised the annual earnings forecast for the group for 2023 to 2025, with more upside projected in tourism recovery in markets it operates in, such as Singapore and the US. Consensus TP suggests an upside of 20.2%, compared to its last close of RM4.88, which is down 4% from a year ago.

https://theedgemalaysia.com/node/701095

These are the stocks analysts favour for 2024.
Gamuda, TM, YTLP, Genting top big-cap picks.

Genting top big-cap picks
Among companies with a market capitalization above RM10 billion, conglomerate Gamuda Bhd tops the list with an overwhelming 20 'buy' calls out of 21 analysts. Analysts cite Gamuda's healthy overseas expansion progress, and their consensus TP of RM5.58 represents 8.3% upside against the stock's Feb 15 close of RM5.15. The counter has risen over 29.7% in the last year.

To all Genting Berhad share holders, Happy and Prosperous New Year. May the year begin with TauRX approval and breaking RM8.00.

Crazy force selling.

1st round Poker game 4.80 to 4.83 all gone.
2nd round Poker game 4.84 - 4.86....waiting

Poker game.
Catching weak holders.....loser.

TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease (AD), announced today that the company will present the 24-month data from its Phase III LUCIDITY trial of hydromethylthionine mesylate (HMTM) at the upcoming AD/PD™ 2024 Alzheimer's & Parkinson's Diseases Conference from 5-9 March 2024, in Lisbon, Portugal.

TauRx has initiated regulatory engagement in the UK and the US for intended product approval. Other territories will follow in line with plans to scale commercialisation of HMTM.

The future of Genting Berhad - TauRX.

Once Taurx approved.......TP RM8.00.
Pray hard hard to God of Heaven on the Seven day of Chinese New Year.

Genting Singapore - Ex rate - RM3.54
Genting US - Ex rate - RM4.76
Genting England - Ex rate - RM5.97

More Profit when convert to Ringgit Malaysia.

Normally Genting Singapore will announce result a day earlier than GenB.
Once GenS result announce, share price could break RM5 if result very good.
Singapore dollars 3.54 could result more profit to GenB.

Believe in yourself.
If you think the future revenue and profit is going to be good for long run, then buy.

Good luck. Happy and Prosperous Chinese new year to all Genting Berhad share holders.

19 years ago ?

According to my broker, A lot bought from him more than RM10 and is still holding.

Just wait until Q4 2023 and total 2023 results. Normally Genting Singapore results out first, should be very good. The share price should go up until GenB results announcement. Hopefully dividend better than last year.

https://www.nst.com.my/business/corporate/2024/01/1002661/resorts-world-sentosa-operator-may-bid-casino-licence-tap-influx

Resorts World Sentosa operator may bid for casino licence to tap influx of foreign tourists.

KUALA LUMPUR: Genting Singapore, the operator of Resorts World Sentosa, may likely be the front-runner to secure a license for an integrated resort (IR) and casino in Thailand if the Thai government decides to deregulate the industry, according to analysts.

can we get more than 10 cents of dividend ?

If China first to approved TauRX, others will follow. Then GenB share sure fly high. Hold tight tight.

TauRX
Huat Ah, Heng Ah, Ong Ah

Why selling when the result is going to be very good ?

Why selling when next month Q4 2023 result is going to be very good ?
Expect better Dividend payout.

F you LKT

Healthy correction before moving up to RM5 again.
Q4 result end of February 2024. TP RM5.50

Very interesting discovery by the Maybank IB team.

16,908 ha freehold land worth more than its mkt cap
GENP is one of the largest freehold land owner in Peninsular Malaysia (PM)
with 16,908 ha, with 61% located in Johor, 18% in Malacca & Negeri
Sembilan, 18% in Kedah & Perak, and 3% in Selangor (ie. Sepang). GENP
continues to carry these valuable assets at their book values. As these
lands were amassed progressively since 1981, and strategically located on
highly populated areas of the west coast of PM, we estimate these freehold
land to be worth MYR7.25b or 1.5x GENP’s current market cap.

Its 10,397 ha Johor land is worth MYR5,656m
GENP has remaining 10,397 ha of freehold land in Johor, of which 2,555 ha
(or 6,311 acres) are located in the Iskandar region, making GENP one of
the largest landowner in Iskandar. GENP has two active township projects
in Johor - at Kulai and Batu Pahat. Since the 1990s, GENP has been
monetising some of its prime estate land via property developments.
Its freehold landbank offers good inflationary hedge
GENP has focused on aggressively growing its oil palm planted area from
48,710 ha in 2003 to 138,301 ha in 2022, translating to a CAGR of 5.4%. As
land values in Malaysia appreciate, most of GENP’s oil palm expansion over
the last two decades shifted to Indonesia. Naturally, the oil palm division
is the larger profit contributor, accounting for 67%-95% of its yearly group
core PBIT over the past 10 years, with the balance contributed by the
property division. In the past, the property division has helped to weather
the earnings of the group during periods of low oil palm profits.

TauRX once approved.
TP RM8.00

https://www.thestar.com.my/business/business-news/2024/01/08/outperforming-------------------------the-fbm-klci-wager

potential progress of Genting Bhd’s TauRx Pharmaceuticals.

https://theedgemalaysia.com/node/696471

Genting Singapore may bid for Thailand casino

https://www.thestar.com.my/business/business-news/2024/01/08/outperforming-------------------------the-fbm-klci-wager

PETALING JAYA: The gaming sector is expected to enter the new year on a positive note with several domestic and external catalysts to spur growth.

UOB Kay Hian Research, which maintained an “overweight” call on the sector, said the gaming stocks would likely outperform the FBM KLCI this year on the back of positive developments including generous dividend yields, Genting Malaysia Bhd’s (GenM) good chances of winning a full-fledged casino licence in downstate New York, and potential progress of Genting Bhd’s TauRx Pharmaceuticals.

TauRX coming soon....watch up
TP : RM8.00

https://theedgemalaysia.com/node/696471

Genting Singapore may bid for Thailand casino — Maybank IB

If Genting TauRX approve in Q1 or Q2 this year.
TP : RM8.00

HLIB said its preferred pick for the sector is Genting ("buy", target price: RM6.96), which is strategically positioned to capitalise on the recovery momentum of both GenS and GenM.

https://theedgemalaysia.com/node/696263

HLIB keeps 'overweight' on gaming sector, Genting top pick.

KUALA LUMPUR (Jan 5): Hong Leong Investment Bank (HLIB) Research has maintained its “overweight” rating of the gaming sector, and said the sector had delivered a steady performance, with notable positive surprises for the third quarter of 2023.

It is confident that the recovery trajectory will be sustainable, especially for casino operators, underpinned by the restoration of global flight capacity and the recent visa-free travel pact between China and both Malaysia and Singapore.

In a sector update, the research house said that as for the number forecast operators, their outlook had stabilised and turned more favourable, with the political status quo maintained in the six state elections last year.
It said the likelihood of additional store closures in other states had diminished, with potential reallocation of closed outlets to other regions.

“All in, we stay 'overweight' on the sector, with Genting Bhd as our preferred pick,” it said.

Casinos
HLIB anticipates continued earnings recovery for Genting Singapore (GenS) and Genting Malaysia Bhd (GenM) in 2024, benefiting Genting, driven by the ongoing rebound in tourist numbers.

“Resorts World Genting and Resorts World Singapore (RWS) are poised to gain from the anticipated revival of Chinese tourists, a crucial client segment for the gaming industry.

“While Singapore and Malaysia showed resilience as destinations for Chinese travellers in the third quarter of 2023, it's important to note that travel volumes were still 21% and 32% below 2019 levels, indicating further potential for recovery.

“Looking ahead to 2024, major music events like the Coldplay and Taylor Swift concerts in Singapore are expected to play a significant role in boosting tourist arrivals, particularly benefiting RWS,” it said.

HLIB said its preferred pick for the sector is Genting ("buy", target price: RM6.96), which is strategically positioned to capitalise on the recovery momentum of both GenS and GenM.

“We also view Genting as currently undervalued, trading at a 16% discount to the value of its holdings in GenS (valued at RM5.54 a share based on the latest closing price, and a Singapore dollar-ringgit exchange rate of 3.4).

Q4 and total 2023 results in February 2024. Share price sure go north. Expect dividend better than last year. Genting Berhad are for long term investment.

Why selling down when Genting Berhad is making good profit and good dividend.
Confirm no more MCO and log down.

Bought 4.60.
Good luck to me.

Please sell to me at 4.60. I have been waiting since yesterday.

Opportunity to accumulate more before Q4 and total year 2023 result Bull run.

Set buy at 4.60.

Genting Berhad is for long term investment.